Fundraising Fox
Stayble Therapeutics
Gothenburg, SE · Founded 2015 · 7 employees on LinkedIn · 1 known investors
Find your way into Stayble Therapeutics
Sign up to see every warm intro you have to Stayble Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stayble Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.
Founders & leadership
AG
Andreas GerwardCEOAndreas Gerward is CEO of Stayble Therapeutics, a clinical-stage pharmaceutical company developing injection-based treatments for disc herniation.
Investors · 1
Frequently asked questions
- What does Stayble Therapeutics do?
- Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.
- Who are Stayble Therapeutics's investors?
- Stayble Therapeutics's investors include Chalmers Ventures AB.
- Where is Stayble Therapeutics headquartered?
- Stayble Therapeutics is headquartered in Gothenburg, SE.